Literature DB >> 2822594

Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis.

C Talmadge1, Y Tanio, A Meeker, J Talmadge, B Zbar.   

Abstract

Studies in tumor biology often require techniques to accurately identify tumors or tumor cell lines. Transfection of plasmid DNA into mammalian cells has been shown to introduce unique genetic markers into recipient cells. These unique genetic markers are detected by Southern transfer. To determine the usefulness of such markers for in vivo studies, a bacterial gene, neo, was transfected into mouse and guinea pig tumor cells. Inbred mice and guinea pigs were injected with syngeneic tumor lines marked with neo. DNA extracted from primary and recurrent tumors and metastases was tested for the presence of the characteristic markers. Integration of neo in cell lines was shown to be stable during tumor growth, recurrence and metastasis, and therefore to be useful for identification of tumors growing in vivo.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822594

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  4 in total

Review 1.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

2.  High-resolution analyses of two different classes of tumor cells in situ tagged with alternative histochemical marker genes.

Authors:  W C Lin; T P Pretlow; T G Pretlow; L A Culp
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

3.  Genetic tagging of tumor cells with retrovirus vectors: clonal analysis of tumor growth and metastasis in vivo.

Authors:  B Korczak; I B Robson; C Lamarche; A Bernstein; R S Kerbel
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

4.  Random process of metastasis and generation of heterogeneity in a mouse sarcoma line.

Authors:  O Niwa; Y Enoki; S Sadamoto; K Kamiya; K Yokoro
Journal:  Jpn J Cancer Res       Date:  1993-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.